East Anglian audit of pembrolizumab in non-small cell lung cancer

被引：0
|
作者：
Jackson, A. H. [1 ]
Fenn, R. [2 ]
Shotton, R. [3 ]
Williams, A. [1 ]
Treece, S. [4 ]
Gkogkou, P. [2 ]
Tasigiannopoulos, Z. [2 ]
Gilligan, D. [5 ]
Yip, K. [1 ]
机构：
[1] Ipswich Hosp, Oncol, Ipswich, Suffolk, England
[2] Nofolk & Norwich Univ Hosp, Oncol, Norwich, Norfolk, England
[3] Cambridge Univ Hosp, Oncol, Cambridge, England
[4] Peterborough City Hosp, Oncol, Peterborough, Cambs, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30120-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
94
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] An audit of pembrolizumab use in non-small cell lung cancer in Nottingham
    Suyanto, S.
    Yeo, D.
    Khan, S.
    LUNG CANCER, 2018, 115 : S39 - S39
  • [2] Pembrolizumab for the treatment of non-small cell lung cancer
    Muller, Mirte
    Schouten, Robert D.
    De Gooijer, Cornedine J.
    Baas, Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 399 - 409
  • [3] Pembrolizumab for the treatment of non-small cell lung cancer
    Lim, Sung Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 397 - 406
  • [4] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
  • [5] Advanced non-small cell lung cancer - treatment with Pembrolizumab
    Silvinato, Antonio
    Floriano, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 256 - 256
  • [6] Advanced non-small cell lung cancer - Treatment with Pembrolizumab
    Silvinato, Antonio
    Floriono, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1423 - 1432
  • [7] Pembrolizumab in non-small cell lung cancer: our experience
    Rizvi, S. A.
    Reza, S.
    Kabba, T.
    Ajzensztejn, D.
    Dwyer, M.
    Randhawa, R.
    Karina, M.
    LUNG CANCER, 2019, 127 : S83 - S83
  • [8] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
    Mazarico Gallego, Jose Ma
    Herrera Juarez, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
  • [9] Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
    Vachhani, Pankit
    Chen, Hongbin
    ONCOTARGETS AND THERAPY, 2016, 9 : 5855 - 5866
  • [10] Pembrolizumab toxicity in non-small cell lung cancer: a retrospective analysis
    Keast, Mary
    Button, Mick
    Case, Amy
    Iqbal, Sahar
    Namelo, Clara
    Powell, Ceri
    Powell, James
    Shaw, Paul
    Cox, Samantha
    LUNG CANCER, 2022, 165 : S37 - S38
12345